BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19442151)

  • 21. Estrogens in human vascular diseases.
    Klouche M
    Ann N Y Acad Sci; 2006 Nov; 1089():431-43. PubMed ID: 17261786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menopausal hormone treatment cardiovascular disease: another look at an unresolved conundrum.
    Harman SM
    Fertil Steril; 2014 Apr; 101(4):887-97. PubMed ID: 24680648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Yue W; Berstein L
    Endocr Relat Cancer; 2003 Jun; 10(2):111-30. PubMed ID: 12790774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
    Saha T; Makar S; Swetha R; Gutti G; Singh SK
    Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicology of environmental estrogens.
    Safe SH; Pallaroni L; Yoon K; Gaido K; Ross S; Saville B; McDonnellc D
    Reprod Fertil Dev; 2001; 13(4):307-15. PubMed ID: 11800169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How sex hormones promote skeletal muscle regeneration.
    Velders M; Diel P
    Sports Med; 2013 Nov; 43(11):1089-100. PubMed ID: 23888432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.
    Iorga A; Cunningham CM; Moazeni S; Ruffenach G; Umar S; Eghbali M
    Biol Sex Differ; 2017 Oct; 8(1):33. PubMed ID: 29065927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Estrogen Receptor in Arterial and Lymphatic Vascular Diseases.
    Fontaine C; Morfoisse F; Tatin F; Zamora A; Zahreddine R; Henrion D; Arnal JF; Lenfant F; Garmy-Susini B
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery.
    Patkar S; Farr TD; Cooper E; Dowell FJ; Carswell HV
    Neurosci Res; 2011 Sep; 71(1):78-84. PubMed ID: 21624404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
    Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
    F1000Res; 2019; 8():. PubMed ID: 31543950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phytochemicals Targeting Estrogen Receptors: Beneficial Rather Than Adverse Effects?
    Lecomte S; Demay F; Ferrière F; Pakdel F
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28657580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.
    Nakamura Y; Suzuki T; Miki Y; Tazawa C; Senzaki K; Moriya T; Saito H; Ishibashi T; Takahashi S; Yamada S; Sasano H
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):17-26. PubMed ID: 15149723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptors as targets for drug development for breast cancer, osteoporosis and cardiovascular diseases.
    Thomas T; Gallo MA; Thomas TJ
    Curr Cancer Drug Targets; 2004 Sep; 4(6):483-99. PubMed ID: 15379634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Licorice root components in dietary supplements are selective estrogen receptor modulators with a spectrum of estrogenic and anti-estrogenic activities.
    Boonmuen N; Gong P; Ali Z; Chittiboyina AG; Khan I; Doerge DR; Helferich WG; Carlson KE; Martin T; Piyachaturawat P; Katzenellenbogen JA; Katzenellenbogen BS
    Steroids; 2016 Jan; 105():42-9. PubMed ID: 26631549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.
    Menazza S; Murphy E
    Circ Res; 2016 Mar; 118(6):994-1007. PubMed ID: 26838792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.
    Albini A; Rosano C; Angelini G; Amaro A; Esposito AI; Maramotti S; Noonan DM; Pfeffer U
    Curr Med Chem; 2014; 21(9):1129-45. PubMed ID: 24304271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of estrogen receptor alpha and ERbeta by 4-methylbenzylidene-camphor in human and rat cells: comparison with phyto- and xenoestrogens.
    Mueller SO; Kling M; Arifin Firzani P; Mecky A; Duranti E; Shields-Botella J; Delansorne R; Broschard T; Kramer PJ
    Toxicol Lett; 2003 Apr; 142(1-2):89-101. PubMed ID: 12765243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β-estradiol adjusts intestinal function via ERβ and GPR30 mediated PI3K/AKT signaling activation to alleviate postmenopausal dyslipidemia.
    Meng Q; Li J; Chao Y; Bi Y; Zhang W; Zhang Y; Ji T; Fu Y; Chen Q; Zhang Q; Li Y; Bian H
    Biochem Pharmacol; 2020 Oct; 180():114134. PubMed ID: 32628929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.